Some have relabeled it as Pentadecapeptide Aringate or PDA (changing the acetate to an arginate) and they are prescribing it for subcutaneous administration that way, whilst the confusion about its standing has led to a vivid oral capsule marketplace for BPC in what seems to generally be a gray space of legality.Is there some kind of conspiracy ver